BioGents

BioGents AG is develops, produces & sells innovative trapping systems against mosquitoes & flies.

Biogents develops, produces & sells innovative trapping systems against mosquitoes & flies, especially against dangerous vectors such as aedes aegypti, aedes albopictus & sand flies. These systems are already being used by leading health organisations (e.g. CDC, USA), several armed forces (e.g. “Bundeswehr”, Germany), other governmetal bodies & public entities (incl. quarantine departments, research institutes & universities). Several consumer versions are marketed since 2009. The technology is protected by two granted patents and was awarded in 2007 by the world bank with money from the Bill & Melinda Gates Foundation. Biogents also offers a feefor-service business for insect repellents and attractants. The company was started in 2003 as a Spin-off from the University of Regensburg.